NASDAQ:RXRX

Recursion Pharmaceuticals Stock News

etoro logo Buy RXRX
*Your capital is at risk
$3.52
+0.180 (+5.39%)
At Close: Jun 26, 2026
SALT LAKE CITY, July 12, 2021 /PRNewswire/ -- Recursion (NASDAQ: RXRX), a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, auto
SALT LAKE CITY, July 1, 2021 /PRNewswire/ -- Recursion (NASDAQ: RXRX), a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, auto

Got $2,500? Check Out These 2 Biotech 2.0 Stocks

06:27am, Thursday, 01'st Jul 2021
They're poised to disrupt the drug development process.
Recursion to open office space within Mila and build machine learning team to focus on some of drug discovery's most challenging problems MONTRÉAL, June 23, 2021 /PRNewswire/ -- Recursion (NASDAQ: RX
The company aims to hire up to 50 people by the end of 2021 across disciplines of data science, machine learning, engineering, product management and computational biology. TORONTO, June 15, 2021 /PRN
Is investor enthusiasm for new biotechnology companies waning? Based on the performance of the 35 biotechs that went public in the first quarter, that may be the case.
SALT LAKE CITY, May 25, 2021 /PRNewswire/ -- Recursion Pharmaceuticals, Inc. (Nasdaq : RXRX), a clinical-stage biotechnology company decoding biology by integrating technological innovations across b

2 Hot Biotech IPOs to Consider

06:33am, Tuesday, 27'th Apr 2021
These companies are already making great strides where few dare to tread.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE